IL-1 binding proteins
First Claim
Patent Images
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide chain amino acid sequence of a binding protein comprising first and second polypeptide chains, wherein said first polypeptide chain comprises a first VD1-(X1)n-VD2-C-(X2)n, wherein:
- VD1 is a first heavy chain variable domain;
VD2 is a second heavy chain variable domain;
C is a heavy chain constant domain;
X1 is a linker with the proviso that it is not CH1;
X2 is an Fc region; and
n is independently 0 or 1; and
wherein said second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n,wherein;
VD1 is a first light chain variable domain;
VD2 is a second light chain variable domain;
C is a light chain constant domain;
X1 is a linker with the proviso that it is not CH1;
X2 does not comprise an Fc region; and
n is independently 0 or 1;
wherein, in said first polypeptide chain, VD1 comprises an amino acid sequence of SEQ ID NO;
204; and
VD2 comprises an amino acid sequence of SEQ ID NO;
213;
wherein, in said second polypeptide chain, VD1 comprises an amino acid sequence of SEQ ID NO;
238; and
VD2 comprises an amino acid sequence of SEQ ID NO;
216; and
wherein the binding protein binds human IL-1β and
human IL-1α
.
2 Assignments
0 Petitions
Accused Products
Abstract
Proteins that bind IL-1α and IL-1β are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1α and IL-1β in cells, tissues, samples, and compositions.
129 Citations
20 Claims
-
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide chain amino acid sequence of a binding protein comprising first and second polypeptide chains, wherein said first polypeptide chain comprises a first VD1-(X1)n-VD2-C-(X2)n, wherein:
-
VD1 is a first heavy chain variable domain; VD2 is a second heavy chain variable domain; C is a heavy chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 is an Fc region; and n is independently 0 or 1; and wherein said second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n, wherein; VD1 is a first light chain variable domain; VD2 is a second light chain variable domain; C is a light chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 does not comprise an Fc region; and n is independently 0 or 1; wherein, in said first polypeptide chain, VD1 comprises an amino acid sequence of SEQ ID NO;
204; and
VD2 comprises an amino acid sequence of SEQ ID NO;
213;wherein, in said second polypeptide chain, VD1 comprises an amino acid sequence of SEQ ID NO;
238; and
VD2 comprises an amino acid sequence of SEQ ID NO;
216; andwherein the binding protein binds human IL-1β and
human IL-1α
.- View Dependent Claims (2, 3, 4, 9, 10, 11, 12, 14, 15, 17, 19)
-
-
5. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide chain amino acid sequence of a binding protein comprising first and second polypeptide chains, wherein said first polypeptide chain comprises a first VD1-(X1)n-VD2-C-(X2)n, wherein:
-
VD1 is a first heavy chain variable domain; VD2 is a second heavy chain variable domain; C is a heavy chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 is an Fc region; and n is independently 0 or 1; and wherein said second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n, wherein; VD1 is a first light chain variable domain; VD2 is a second light chain variable domain; C is a light chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 does not comprise an Fc region; and n is independently 0 or 1; wherein said first polypeptide chain comprises an amino acid sequence of SEQ ID NO;
212;
wherein said second polypeptide chain comprises an amino acid sequence of SEQ ID NO;
215; andwherein the binding protein binds human IL-1β and
human IL-1α
.- View Dependent Claims (6, 7, 8, 13, 16, 18, 20)
-
Specification